Global Genetic Testing Market Report 2023-2027: New Knowledge, Combined with Lower Pricing is Driving the Genetic Testing Industry to Record Growth
The new report from ResearchAndMarkets.com forecasts significant growth in the global genetic testing market from 2023 to 2027, driven by advancements in genetic understanding and reduced testing costs. With various applications like newborn screening, oncology, and direct-to-consumer testing, the market is experiencing increased demand. The report provides extensive analysis across 14 countries and covers pivotal technologies such as PCR and NGS. Notably, factors like pharmacogenomics and the rise of personalized medicine are expected to propel market expansion. Companies are urged to leverage this data for informed decision-making.
- Market expected to grow significantly from 2023 to 2027 due to lower testing costs and better genetic understanding.
- New applications in newborn screening and oncology are driving demand.
- Comprehensive analysis provided for 14 countries, enhancing market insights.
- Increased competition may lead to price reductions, affecting profit margins.
- The report suggests testing usage analysis may curtail growth potential.
This research makes you the expert in your organization. Make investment decisions and valuations with confidence using the latest data.
Unlimited growth potential. What has happened to Direct to Consumer testing? Will all newborns receive Whole Genomic Sequencing at birth?
The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth.
New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.
Key Topics Covered:
1 Market Guides
1.1 Genetic Testing - Strategic Situation Analysis & Company Rankings
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for
2 Introduction and Market Definition
2.1 Genetic Testing Definition in This Report
2.2 The Genomics Revolution
2.3 Market Definition
2.3.1 Revenue Market Size
2.3.2 Newborn Screening
2.3.3 Non Invasive Pregnancy Testing
2.3.4 Predictive
2.3.5 Oncology
2.3.6 Direct to Consumer
2.3.7 Other Application
2.3.8 PCR
2.3.9 NGS
2.4 Methodology
2.5 Perspective: Healthcare and the IVD Industry
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics
2.6 Chromosomes, Genes and Epigenetics
2.6.1 Chromosomes
2.6.2 Genes
2.6.3 Epigenetics
3 Market Overview
3.1 Players in a Dynamic Market
3.1.1
3.1.2 Diagnostic Test Developer
3.1.3 Instrumentation Supplier
3.1.4 Chemical/Reagent Supplier
3.1.5 Pathology Supplier
3.1.6
3.1.7
3.1.8
3.1.9
3.2 Genetic Tests - Types, Examples and Discussion
3.2.1 Preimplantation Genetic Diagnosis- An Emerging Market
3.2.2 Prenatal Diagnosis - New Technologies Create Opportunity
3.2.3 Newborn Screening
3.2.4 Diagnostic Testing
3.2.5 Carrier Testing
3.2.6 Predictive and Presymptomatic Testing
3.2.7 Pharmacogenomics
3.2.8 Forensic Testing
3.2.9 Parental Testing
3.3 Industry Structure
3.3.1 Hospital's Testing Share
3.3.2 Economies of Scale
3.3.3 Hospital vs.
3.3.4
3.3.5 Physician's and POCT
4 Market Trends
4.1 Factors Driving Growth
4.1.1 Genetic Discoveries Creating New Diagnostic Markets
4.1.2 The Aging Effect
4.1.3 Pharmacogenomics Drives Further Growth.
4.1.4 Oncology and Liquid Biopsy Enter New Era
4.1.5 Fertility Practice Growth drives market
4.1.6 Direct to Consumer begins to break out
4.2 Factors Limiting Growth
4.2.1 Increased Competition Lowers Price
4.2.2 Lower Costs
4.2.3 Testing usage analysis curtailing growth
4.2.4 Wellness has a downside
4.3 Instrumentation, Automation and Diagnostic Trends
4.3.1 Traditional Automation and Centralization
4.3.2 The New Automation, Decentralization and Point of Care
4.3.3 Instruments Key to Market Share
4.3.4 Bioinformatics Plays a Role
4.3.5 PCR Takes Command
4.3.6
4.3.7 NGS Impact on Pricing
4.3.8 Whole Genome Sequencing, A
4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
5 Genetic Testing Recent Developments
5.1 Recent Developments
5.2 Genomics England, Aims to Sequenc00K Newborns
5.3 Juno Diagnostics NIPT With At-Home Sample Collection
5.4 Cardio Diagnostics Launches Genetic
5.5 Universal Genetic Testing in Breast Cancer Further Supported
5.6 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
5.7
5.8 Typ Diabetes GWAS Enables Risk Prediction
5.9 LetsGetChecked to Acquire Veritas Genetics
5.10 Guardant Health Plans New Comprehensive Assay
5.11 Tesis Labs Raises
5.12 Sema4: Sema4 Elements
5.13 Clarified Precision Medicine Acquires Interpares Biomedicine
5.14 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
5.15 Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
5.16
5.17 Progenity Revenues Fall on COVID-19 Effect
5.18 Natera Launches Tumor Genomic Profiling Assay
5.13andMe To Go Public
5.20 Guardant Health to Offer Tumor Tissue Sequencing
5.21 Ancestry Quits Health Offering
5.22 DTC Firm MyDNA Merges With Gene by Gene
5.23 Aetna Coverage for NIPT to Include All Pregnancies
5.24 Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing
5.25 Tumor, Germline Testing of Cancer Patients Can Give Discordant Results
6 Profiles of Key Companies
6.1 10x Genomics, Inc1
6.2 3andME Inc.
6.3 Abbott Laboratories
6.4 Adaptive Biotechnologies
6.5
6.6 Agilent/Dako
6.7
6.8 Amoy Diagnostics Co., Ltd1
6.9
6.10 Anchor Dx
6.11 Arc Bio
6.12 Arrayit Corporation
6.13
6.14
6.15
6.16
6.17
6.18 BGI Genomics Co. Ltd
6.19 Bioarray Genetics
6.20 Biocept, Inc.
6.21 Biodesix Inc.
6.22 BioFluidica
6.23
6.24 Biolidics Ltd
6.25 bioMerieux Diagnostics
6.26 Bioneer Corporation
6.27 Bio-Rad Laboratories, Inc
6.28 Bio-Techne
6.29 C2i Genomics
6.30
6.31 CellMax Life
6.32 Centogene
6.33
6.34 Circulogene
6.35 Clinical Genomics
6.36 Color Genomics
6.37
6.38
6.39
6.40 Diasorin S.p.A
6.41 Epic Sciences
6.42 Epigenomics AG
6.43 Eurofins Scientific
6.44 Excellerate Bioscience
6.45 Fabric Genomics
6.46 Freenome
6.47
6.48
6.49 Fulgent Genetics
6.50 Gene by
6.51 Genedrive
6.52
6.53
6.54 Genomics England
6.55
6.56 GenomOncology
6.57
6.58 Grifols
6.59 Guardant Health
6.60 Guardiome
6.61 HeiScreen
6.62 Helix
6.63
6.64 Hologic
6.65 HTG Molecular Diagnostics
6.66
6.67 iCellate
6.68 Illumina
6.69 Incell Dx
6.70
6.71
6.72 Invitae Corporation
6.73 Invivoscribe
6.74 Karius
6.75 Lunglife AI Inc
6.76 Macrogen
6.77
6.78
6.79 Medgenome
6.80
6.81 Meridian Bioscience
6.82 Mesa Biotech (Thermo Fisher)
6.83 Mesa Laboratories, Inc
6.84 miR Scientific
6.85
6.86 NantHealth, Inc
6.87 Natera
6.88 Nebula Genomics
6.89 NeoGenomics
6.90
6.91 NGeneBi
6.92
6.93 Omega Bioservices
6.94 Oncocyt
6.95 OncoDNA
6.96 OpGen
6.97
6.98
6.99 Oxford Nanopore Technologies
6.100 Panagene
6.101 Perkin Elmer
6.102
6.103 Personalis
6.104 Precipio
6.105 PrecisionMed
6.106
6.107
6.108 Qiagen
6.109
6.110
6.111 Roswell Biotechnologies
6.112 Seegen
6.113 Sema4 Holdings
6.114 Sequencing.com
6.115 Siemens Healthineers
6.116 simfo
6.117
6.118 SkylineDx
6.119 Standard BioTools
6.120
6.121 Sysmex
6.122 Sysmex Inostics
6.123
6.124 Thermo Fisher Scientific Inc
6.125 Variantyx
6.126 Volition
6.127 Vyant Bio
7 Global Market Size
7.1 Global Market by Country
7.2 Global Market by Application
7.3 Global Market by Technology
7.4 Global Market by Product
7.5 Global Market by User
8 Market Sizes by Application
8.1 Newborn Testing Market
8.2 NIPT Market
8.3 Predictive Testing Market
8.4 Oncology Testing Market
8.5 DTC Testing Market
8.6 Other Testing Market
9 Global Genetic Testing Market by Technology
9.1 PCR Testing Market
9.2 NGS Market
9.3 Cytogenetic Testing Market
9.4 Other Testing Market
10 Global Genetic Testing Market by Product
10.1 Instruments Market
10.2 Reagents and Kits Marke
10.3 Software Market
10.4 Services Market
11 Global Genetic Testing Market by User
11.1 Academic Market
11.2 Clinical Market
11.3 Pharmaceutical Market
11.4 Industrial and Other Market
12 The Future of Genetic Testing
13 Appendices
13.1 United States Medicare System: Laboratory Fees Schedule
13.2 The Most Used IVD Assays
13.3 The Highest Grossing Assays
For more information about this report visit https://www.researchandmarkets.com/r/bklnfl-testing?w=5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For
For GMT Office Hours Call +353-1-416-8900
Fax (outside
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE
FAQ
What is the forecast for the genetic testing market from 2023 to 2027?
How will lower pricing impact the genetic testing industry?
What are the key applications driving the genetic testing market?
What technologies are included in the genetic testing market report?